Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

COMBIVIR for Maternal exposure timing unspecified: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where COMBIVIR was used for Maternal exposure timing unspecified.

Most Reported Side Effects for COMBIVIR

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 24 22.2% 4 6
Exposure during pregnancy 17 15.7% 0 3
Abortion spontaneous 12 11.1% 1 0
Anaemia 7 6.5% 0 5
Stillbirth 7 6.5% 1 0
Lipodystrophy acquired 6 5.6% 0 0
Abortion induced 5 4.6% 2 0
Diarrhoea 5 4.6% 0 1
Rash 5 4.6% 0 3

Other Indications for COMBIVIR

Hiv infection (62) Antiretroviral therapy (15) Product used for unknown indication (9)

Other Drugs Used for Maternal exposure timing unspecified

VALPROATE (1,477) ADALIMUMAB (1,280) NATALIZUMAB (492) RITONAVIR (486) EMTRICITABINE\TENOFOVIR DISOPROXIL (333) LOPINAVIR\RITONAVIR (278) DIVALPROEX (254) INTERFERON BETA-1A (245) DIMETHYL (212) ATAZANAVIR (169)

Related Pages

COMBIVIR Full Profile All Maternal exposure timing unspecified Drugs COMBIVIR Demographics COMBIVIR Timeline